Chlorothiazide Sodium Injection, Powder, Lyophilized, For Solution
Product Images NDC 68083-614
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Chlorothiazide Sodium (NDC 68083-614). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chlorothiazide-spl-carton (Chlorothiazide Spl Carton)
This text provides information about chlorothiazide sodium for injection in single-dose vials. The medication is used for the preparation of intravenous solutions and each vial contains chlorothiazide sodium equivalent to 500 mg of the active ingredient. The reconstituted solution should be clear and free from visible particles. Instructions are included on reconstitution and dosage administration for adults. The medication should be stored at a controlled room temperature between 20° to 25°C. It is indicated for prescription use only. The manufacturing information is also provided.*
Chlorothiazide-spl-label (Chlorothiazide Spl Label)
This is a prescription medication labeled as "Sodium for Injection, USP 500 mg/vial" by Gland Pharma Limited based in Hyderabad, India. The medication is intended for the preparation of intravenous solutions and is available in a sterile, lyophilized, single-dose vial. The National Drug Code (NDC) for this product is 68083-614-01.*
Chlorothiazide-spl-structure-1.jpg (Chlorothiazide Spl Structure 1)
Chlorothiazide-spl-structure-2.jpg (Chlorothiazide Spl Structure 2)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.